LMO3 |
NUTM1 |
||
---|---|---|---|
Gene Name | LIM domain only 3 (rhombotin-like 2) | NUT midline carcinoma, family member 1 | |
Image | No pdb structure | No pdb structure | |
Gene Ontology Annotations | Cellular Component | ||
Molecular Function | |||
Biological Process |
|
||
Pathways | |||
Drugs | |||
Diseases | |||
GWAS | |||
Protein-Protein Interactions | 33 interactors: AIMP2 BANP CARF CCDC33 CCDC85B CEP170P1 CEP57L1 FAM131C FBLIM1 FOS GABPB1 HNRNPC HNRNPM IKZF1 KCTD1 KXD1 LDB1 LDB2 MBIP MDFI NBPF22P NHLH2 NUTM1 PHC2 RALYL RFX6 RORA SAMD3 SP4 SPERT TAX1BP1 ZBTB43 ZBTB8A | 23 interactors: ALOX5 CCHCR1 EP300 FAM161A HSPBAP1 IFIT2 KANSL1 KPNA2 LHX8 LMO1 LMO2 LMO3 MORN4 NEBL P4HA3 PRKAA2 PSME4 RIC8A SAMD4A SH2D4A TP53BP2 ZMYND10 ZNF277 | |
Entrez ID | 55885 | 256646 | |
HPRD ID | 11832 | 10606 | |
Ensembl ID | ENSG00000048540 | ENSG00000184507 | |
Uniprot IDs | Q8TAP4 Q9NYC6 | Q86Y26 | |
PDB IDs | |||
Enriched GO Terms of Interacting Partners? |
|
||
Tagcloud ? | aggressive
aggressiveness
atypical
benign
biosignatures
clinically
constitute
decisions
demand
forty
fourteen
histologically
igf1r
meningioma
meningiomas
metabolic
mostly
nmr
oligonucleotide
otherwise
predominant
proceeds
profiles
recur
recurrence
relevance
subgroup
subgroups
turnover
|
||
Tagcloud (Difference) ? | aggressive
aggressiveness
atypical
benign
biosignatures
clinically
constitute
decisions
demand
forty
fourteen
histologically
igf1r
meningioma
meningiomas
metabolic
mostly
nmr
oligonucleotide
otherwise
predominant
proceeds
profiles
recur
recurrence
relevance
subgroup
subgroups
turnover
|
||
Tagcloud (Intersection) ? |